This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Differentiation is becoming increasingly important in the strategies of biosimilar companies with >700 biosimilar products in development, many of these being developed for major territories. Arecor can deliver meaningful commercial differentiation and intellectual property protection via innovative reformulation of its partners’ biosimilar products.